BIENAIME JEAN JACQUES
CIK 1221590
Transactions on file
22
Open-market buys
14
Win rate (buys)
21%
14 scored
Avg % since filing (buys)
+18.1%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-10 | 2026-06-08 | INCY INCYTE CORP | Director | Grant | 1,642 | $0.00 | — | open → |
| 2026-06-09 | 2026-06-05 | IMNM Immunome Inc. | Buy | 1,000 | $19.3K | -5.8% | open → | |
| 2026-06-09 | 2026-06-05 | IMNM Immunome Inc. | Buy | 3,500 | $68.1K | -6.7% | open → | |
| 2026-06-09 | 2026-06-05 | IMNM Immunome Inc. | Buy | 6,000 | $116.9K | -6.8% | open → | |
| 2026-06-09 | 2026-06-05 | IMNM Immunome Inc. | Sale | 10,000 | $194.1K | -6.4% | open → | |
| 2026-06-09 | 2026-06-05 | IMNM Immunome Inc. | Sale | 500 | $9.7K | -6.6% | open → | |
| 2026-06-05 | 2026-06-03 | KROS Keros Therapeutics, Inc. | Grant | 7,142 | $0.00 | — | open → | |
| 2026-06-01 | 2026-05-29 | ASND Ascendis Pharma A/S | Buy | 100 | $22.4K | -6.1% | open → | |
| 2026-06-01 | 2026-05-29 | ASND Ascendis Pharma A/S | Buy | 200 | $44.5K | -5.6% | open → | |
| 2026-06-01 | 2026-05-29 | ASND Ascendis Pharma A/S | Buy | 200 | $44.8K | -6.2% | open → | |
| 2026-05-28 | 2026-05-26 | INCY INCYTE CORP | Director | Tax | 13,059 | $1.27M | +8.5% | open → |
| 2026-05-28 | 2026-05-26 | INCY INCYTE CORP | Director | Exer. | 15,000 | $1.27M | +24.7% | open → |
| 2026-05-27 | 2026-05-26 | ASND Ascendis Pharma A/S | Buy | 200 | $47.9K | -12.4% | open → | |
| 2026-05-27 | 2026-05-26 | ASND Ascendis Pharma A/S | Buy | 200 | $47.2K | -11.2% | open → | |
| 2026-05-19 | 2026-05-15 | KROS Keros Therapeutics, Inc. | Buy | 1,000 | $10.6K | -6.1% | open → | |
| 2026-05-19 | 2026-05-15 | IMNM Immunome Inc. | Buy | 5,000 | $103.5K | -12.3% | open → | |
| 2026-04-17 | 2026-04-15 | KROS Keros Therapeutics, Inc. | Buy | 1,000 | $11.7K | -15.1% | open → | |
| 2025-03-25 | 2025-03-24 | IMNM Immunome Inc. | Director | Buy | 7,000 | $57.5K | +121.2% | open → |
| 2025-03-26 | 2025-03-25 | IMNM Immunome Inc. | Director | Buy | 7,800 | $60.7K | +133.4% | open → |
| 2025-06-03 | 2025-06-03 | IMNM Immunome Inc. | Director | Buy | 5,000 | $46.9K | +93.6% | open → |
| 2025-06-06 | 2025-06-04 | KROS Keros Therapeutics, Inc. | Director | Grant | 5,250 | $0.00 | — | open → |
| 2025-06-12 | 2025-06-10 | INCY INCYTE CORP | Director | Grant | 2,518 | $0.00 | — | open → |
